Literature DB >> 17380198

Structure and enzymatic functions of human CD38.

Hon Cheung Lee1.   

Abstract

CD38 is a novel multifunctional protein that serves not only as an antigen but also as an enzyme. It catalyzes the metabolism of cyclic ADP-ribose and nicotinic acid adenine dinucleotide phosphate, two structurally and functionally distinct Ca(2+) messengers targeting, respectively, the endoplasmic reticulum and lysosomal Ca(2+) stores. The protein has recently been crystallized and its three-dimensional structure solved to a resolution of 1.9 A. The crystal structure of a binary complex reveals critical interactions between residues at the active site and a bound substrate, providing mechanistic insights to its novel multi-functional catalysis. This article reviews the current advances in the understanding of the structural determinants that control the multiple enzymatic reactions catalyzed by CD38.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17380198      PMCID: PMC1829193          DOI: 10.2119/2006–00086.Lee

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  69 in total

1.  NAADP mobilizes Ca(2+) from reserve granules, lysosome-related organelles, in sea urchin eggs.

Authors:  Grant C Churchill; Yuhei Okada; Justyn M Thomas; Armando A Genazzani; Sandip Patel; Antony Galione
Journal:  Cell       Date:  2002-11-27       Impact factor: 41.582

2.  Sperm deliver a new second messenger: NAADP.

Authors:  Grant C Churchill; John S O'Neill; Roser Masgrau; Sandip Patel; Justyn M Thomas; Armando A Genazzani; Antony Galione
Journal:  Curr Biol       Date:  2003-01-21       Impact factor: 10.834

Review 3.  Recent advances in the Okamoto model: the CD38-cyclic ADP-ribose signal system and the regenerating gene protein (Reg)-Reg receptor system in beta-cells.

Authors:  Hiroshi Okamoto; Shin Takasawa
Journal:  Diabetes       Date:  2002-12       Impact factor: 9.461

4.  Cyclic ADP-ribose production by CD38 regulates intracellular calcium release, extracellular calcium influx and chemotaxis in neutrophils and is required for bacterial clearance in vivo.

Authors:  S Partida-Sánchez; D A Cockayne; S Monard; E L Jacobson; N Oppenheimer; B Garvy; K Kusser; S Goodrich; M Howard; A Harmsen; T D Randall; F E Lund
Journal:  Nat Med       Date:  2001-11       Impact factor: 53.440

5.  Crystallographic studies on human BST-1/CD157 with ADP-ribosyl cyclase and NAD glycohydrolase activities.

Authors:  Sumie Yamamoto-Katayama; Mariko Ariyoshi; Katsuhiko Ishihara; Toshio Hirano; Hisato Jingami; Kosuke Morikawa
Journal:  J Mol Biol       Date:  2002-02-22       Impact factor: 5.469

6.  A novel cycling assay for cellular cADP-ribose with nanomolar sensitivity.

Authors:  Richard Graeff; Hon Cheung Lee
Journal:  Biochem J       Date:  2002-01-15       Impact factor: 3.857

7.  A novel mechanism for coupling cellular intermediary metabolism to cytosolic Ca2+ signaling via CD38/ADP-ribosyl cyclase, a putative intracellular NAD+ sensor.

Authors:  Li Sun; Olugbenga A Adebanjo; Anatoliy Koval; Hindupur K Anandatheerthavarada; Jameel Iqbal; Xing Y Wu; Baljit S Moonga; Xue B Wu; Gopa Biswas; Peter J R Bevis; Masoyoshi Kumegawa; Solomon Epstein; Christopher L-H Huang; Narayan G Avadhani; Etsuko Abe; Mone Zaidi
Journal:  FASEB J       Date:  2002-03       Impact factor: 5.191

8.  Cyclic ADP-ribose is a second messenger in the lipopolysaccharide-stimulated proliferation of human peripheral blood mononuclear cells.

Authors:  Santina Bruzzone; Antonio De Flora; Cesare Usai; Richard Graeff; Hon Cheung Lee
Journal:  Biochem J       Date:  2003-10-15       Impact factor: 3.857

9.  A novel cycling assay for nicotinic acid-adenine dinucleotide phosphate with nanomolar sensitivity.

Authors:  Richard Graeff; Hon Cheung Lee
Journal:  Biochem J       Date:  2002-10-01       Impact factor: 3.857

10.  Disordered osteoclast formation and function in a CD38 (ADP-ribosyl cyclase)-deficient mouse establishes an essential role for CD38 in bone resorption.

Authors:  Li Sun; Jameel Iqbal; Svetlana Dolgilevich; Tony Yuen; Xue-Bin Wu; Baljit S Moonga; Olugbenga A Adebanjo; Peter J R Bevis; Frances Lund; Christopher L-H Huang; Harry C Blair; Etsuko Abe; Mone Zaidi
Journal:  FASEB J       Date:  2003-03       Impact factor: 5.191

View more
  65 in total

1.  CD38 expression in early B-cell precursors contributes to extracellular signal-regulated kinase-mediated apoptosis.

Authors:  Héctor Romero-Ramírez; Monserrat Teresa Morales-Guadarrama; Rosana Pelayo; Rubén López-Santiago; Leopoldo Santos-Argumedo
Journal:  Immunology       Date:  2015-02       Impact factor: 7.397

2.  CD38 and CD157: biological observations to clinical therapeutic targets.

Authors:  Amy Warenda Czura; Christopher J Czura
Journal:  Mol Med       Date:  2006 Nov-Dec       Impact factor: 6.354

3.  Characterization of CD38 in the major cell types of the heart: endothelial cells highly express CD38 with activation by hypoxia-reoxygenation triggering NAD(P)H depletion.

Authors:  James Boslett; Craig Hemann; Fedias L Christofi; Jay L Zweier
Journal:  Am J Physiol Cell Physiol       Date:  2017-11-29       Impact factor: 4.249

4.  Transformation and action of extracellular NAD+ in perfused rat and mouse livers.

Authors:  Ana Carla Broetto-Biazon; Fabrício Bracht; Livia Bracht; Ana Maria Kelmer-Bracht; Adelar Bracht
Journal:  Acta Pharmacol Sin       Date:  2008-12-15       Impact factor: 6.150

5.  CD38 Inhibits Prostate Cancer Metabolism and Proliferation by Reducing Cellular NAD+ Pools.

Authors:  Jeffrey P Chmielewski; Sarah C Bowlby; Frances B Wheeler; Lihong Shi; Guangchao Sui; Amanda L Davis; Timothy D Howard; Ralph B D'Agostino; Lance D Miller; S Joseph Sirintrapun; Scott D Cramer; Steven J Kridel
Journal:  Mol Cancer Res       Date:  2018-08-03       Impact factor: 5.852

Review 6.  The secret life of NAD+: an old metabolite controlling new metabolic signaling pathways.

Authors:  Riekelt H Houtkooper; Carles Cantó; Ronald J Wanders; Johan Auwerx
Journal:  Endocr Rev       Date:  2009-12-09       Impact factor: 19.871

7.  Daratumumab induces CD38 internalization and impairs myeloma cell adhesion.

Authors:  Jayeeta Ghose; Domenico Viola; Cesar Terrazas; Enrico Caserta; Estelle Troadec; Jihane Khalife; Emine Gulsen Gunes; James Sanchez; Tinisha McDonald; Guido Marcucci; Balveen Kaur; Michael Rosenzweig; Jonathan Keats; Steven Rosen; Amrita Krishnan; Abhay R Satoskar; Craig C Hofmeister; Flavia Pichiorri
Journal:  Oncoimmunology       Date:  2018-07-23       Impact factor: 8.110

8.  CD38 and CD157 ectoenzymes mark cell subsets in the human corneal limbus.

Authors:  Alberto L Horenstein; Federico Sizzano; Riccardo Lusso; Federico Genzano Besso; Enza Ferrero; Silvia Deaglio; Franco Corno; Fabio Malavasi
Journal:  Mol Med       Date:  2008-11-19       Impact factor: 6.354

9.  8-Bromo-cyclic inosine diphosphoribose: towards a selective cyclic ADP-ribose agonist.

Authors:  Tanja Kirchberger; Christelle Moreau; Gerd K Wagner; Ralf Fliegert; Cornelia C Siebrands; Merle Nebel; Frederike Schmid; Angelika Harneit; Francesca Odoardi; Alexander Flügel; Barry V L Potter; Andreas H Guse
Journal:  Biochem J       Date:  2009-07-29       Impact factor: 3.857

10.  Structural basis for enzymatic evolution from a dedicated ADP-ribosyl cyclase to a multifunctional NAD hydrolase.

Authors:  Qun Liu; Richard Graeff; Irina A Kriksunov; Hong Jiang; Bo Zhang; Norman Oppenheimer; Hening Lin; Barry V L Potter; Hon Cheung Lee; Quan Hao
Journal:  J Biol Chem       Date:  2009-07-28       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.